Cetrizet

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetrizet

Property Description
Active Ingredient Cetirizine
Form Oral Tablet, Capsule, or Syrup
Pharmacological Class Second-Generation Antihistamine; H1 Receptor Antagonist
Common Use Symptomatic relief of seasonal and perennial allergies
Origin Synthetic

Cetrizet: At a Glance (Identity and Pharmacological Type)

The medication known as Cetrizet is a brand-name product featuring Cetirizine as its active ingredient. Cetirizine is a widely used compound that is internationally classified as a second-generation antihistamine. This classification is important because these newer agents are highly selective in their action.

Cetirizine functions as a Histamine H1-receptor antagonist. It is clinically recognized for its ability to block the action of histamine, the natural chemical that causes many common allergy symptoms. A key differentiating feature of this second-generation drug is its reduced ability to penetrate the central nervous system, which minimizes the sedation often associated with older antihistamines.


Composition and Origin (Source and Formulation)

Cetrizet's active substance, Cetirizine dihydrochloride, is a synthetic chemical compound that is manufactured to ensure consistent purity and standardized efficacy. The medication is commonly available for the oral route of administration in forms such as tablets, capsules, and liquid syrup.

This variety in formulation, particularly the availability of an oral solution, allows Cetrizet to be suitable for a broader patient group, including young children, offering flexible use options beyond standard adult tablets.


Primary Therapeutic Purpose (General Use)

The primary therapeutic purpose of Cetrizet is the symptomatic relief of allergic manifestations, which include common issues like hay fever, perennial (year-round) allergies, and skin reactions such as hives (urticaria). The drug is generally prescribed to alleviate the discomfort arising from the body's overreaction to allergens.

A typical use scenario involves taking the medication once daily to manage symptoms associated with continuous exposure to allergens like dust mites or pollen. It is important to note that the medicine manages the symptoms; it does not eliminate the underlying immunological cause of the allergy itself.

Regulatory References

  1. Cetirizine Monograph (NIH/StatPearls)
  2. Cetirizine Drug Information (MedlinePlus/NIH)

What side effects are possible with Cetrizet?

Possible Side Effects and Safety Information

The safety profile for medications containing Cetirizine (Cetrizet) is officially documented by government regulatory bodies, classifying potential adverse reactions by the physiological systems they affect and the frequency with which they are reported.

Commonly Documented Adverse Reactions

Adverse effects listed as Common—meaning they may affect up to 1 in 10 patients—are often associated with the nervous and gastrointestinal systems. These include somnolence (drowsiness), fatigue, headache, dizziness, dry mouth, and pharyngitis (sore throat).

Rare and Serious Adverse Reactions

Reactions classified as Rare or Very Rare are of higher clinical significance. Rare effects (up to 1 in 1,000 patients) include hypersensitivity reactions, convulsions, and documented abnormal hepatic function (liver issues). Very Rare effects (less than 1 in 10,000 patients) include severe outcomes such as anaphylactic shock (a serious, life-threatening allergic reaction), syncope (fainting), and specific movement disorders.

Safety-Related Restrictions and Considerations

The medicine is contraindicated in individuals with a known hypersensitivity to the active substance or related compounds. Use requires particular caution in patients with renal impairment, where dosage adjustment is typically necessary, and is contraindicated in severe renal disease. Official labeling also notes that combining the medication with alcohol or other CNS depressants may cause an additive reduction in alertness and impaired performance. A safety pattern specifically noted after long-term daily use is the potential for severe pruritus (itching) upon discontinuation.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the documented clinical signs and mandated emergency actions for Cetirizine overdose, based strictly on official government regulatory labeling. The presentation following excessive intake often relates to effects on the central nervous system (CNS).

Domain Official Regulatory Statements
Documented Overdose Manifestations Clinical signs observed following high-dose ingestion (e.g., five times the recommended daily dose) include somnolence, drowsiness, fatigue, headache, restlessness, and dizziness. More severe manifestations affecting the CNS and cardiovascular systems, such as tachycardia (rapid heartbeat), convulsions (seizures), and mydriasis (dilated pupils), are also documented in regulatory reports.
Antidote & Supportive Care There is no known specific antidote to Cetirizine. Treatment is officially limited to symptomatic or supportive treatment for the observed clinical signs. Gastric lavage may be considered shortly after ingestion, but official documents state the substance cannot be effectively removed by dialysis.

Emergency Action Required

In case of suspected overdose, all regulatory bodies mandate individuals seek professional assistance immediately or contact a Poison Control Center right away. Calling emergency services (911) is required if the victim collapses, has a seizure, experiences difficulty breathing, or cannot be awakened. The overdose profile explicitly notes that effects, such as irritability and then drowsiness, have been specifically documented in the pediatric population.

Regulatory Basis

This profile defining risks and actions is derived from government-authorized documents, including the Summary of Product Characteristics (SmPC) and FDA labeling.

Therapeutic Uses of Cetrizet

Quick Facts

  • Relieves Symptoms Related to Seasonal Allergies: May help manage sneezing, runny nose, and itchy or watery eyes associated with hay fever and other upper respiratory allergies.
  • Assists with Perennial Allergic Rhinitis: Helps provide relief from year-round nasal and ocular symptoms caused by indoor allergens.
  • Manages Chronic Hives: Used to help ease the symptoms of chronic idiopathic urticaria, including itching and redness of the skin.

What Cetrizet Treats: Main Uses and Benefits

Cetrizet is a widely used medication intended to provide symptom relief for a range of allergic conditions. Its use is focused on addressing the noticeable manifestations of allergic reactions, helping patients manage daily discomfort.

The primary therapeutic domains for Cetrizet involve the relief of symptoms associated with both seasonal and perennial allergic rhinitis. For individuals experiencing seasonal allergies, such as hay fever, the medication helps to alleviate sneezing, a runny nose (rhinorrhea), and itchy or watery eyes (ocular symptoms). It also helps manage similar year-round symptoms that may be triggered by indoor allergens, known as perennial allergic rhinitis.

Furthermore, Cetrizet is indicated for use in managing chronic idiopathic urticaria (hives). In this context, the medication is intended to reduce the itching (pruritus) and redness associated with chronic hives. The objective of treatment is to ease discomfort and support a greater sense of well-being for the patient.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cetrizet

The eligibility profile for Cetrizet is defined by official regulatory documentation, outlining populations for whom use is permitted, restricted, or contraindicated.

Category Eligibility Status as Stated in Label
Populations Contraindicated Patients with known hypersensitivity to Cetirizine, hydroxyzine, or piperazine derivatives are contraindicated. Use is also contraindicated in those with severe renal impairment (creatinine clearance < 10 mL/min).
Age-Related Rules Use is generally established for adults and adolescents (12 years). Specific formulations are approved for children as young as 6 months for certain indications. Children under 6 years and older adults (65 years) should consult a health professional.
Organ Function Restriction Individuals with moderate renal impairment require a lower, specific dose due to reduced drug clearance. While isolated hepatic impairment may not require adjustment, professional consultation is advised.
Special Conditions Caution is recommended for patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia) and those with epilepsy or risk of convulsions.
Pregnancy/Lactation Regulatory warnings advise consulting a health professional if pregnant. Use during breastfeeding is generally not recommended due to drug excretion into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cetrizet (cetirizine) has a documented interaction profile primarily focused on substances that affect the central nervous system (CNS) and certain pharmacokinetic alterations.

Key Interaction Domains and Constraints

Interacting Product Category Official Constraint/Finding Regulatory Basis (Mechanism)
CNS Depressants and Alcohol Concurrent use should be avoided or used with due caution due to the risk of additive CNS impairment. Pharmacodynamic; increased sedation and reduction in alertness.
Theophylline A small decrease in cetirizine clearance was observed when coadministered with a 400 mg dose of Theophylline. Pharmacokinetic; clearance rate alteration.
Ritonavir Plasma concentrations of cetirizine are increased by approximately 40–45% when coadministered. Pharmacokinetic; P-glycoprotein (P-gp) efflux transporter effects.
Drugs that Lower Seizure Threshold Cetirizine may increase the toxicity of these products, necessitating careful clinical management. Pharmacodynamic; increased risk of seizure activity.

Official Interaction Statements

  • The use of Cetrizet with alcohol or other CNS depressants (e.g., sedatives, tranquilizers) is associated with an increased risk of drowsiness and impairment of performance. Due caution must be exercised, and combination should be avoided to prevent additional reductions in mental alertness.
  • No clinically significant drug interactions have been found with low-dose Theophylline or with standard doses of Azithromycin and Pseudoephedrine.
  • Concomitant use with Ritonavir requires monitoring for potential signs of increased cetirizine exposure, such as enhanced sedation, due to the documented increase in cetirizine concentration.

This structure reflects the official regulatory constraints, which principally advise caution regarding additive CNS effects and note specific pharmacokinetic interactions with a limited number of medicines.

Mechanism of Action

Selective Peripheral H₁ Receptor Antagonism

The drug's primary action is to function as a selective inverse antagonist at the peripheral Histamine H1 receptor. This mechanism blocks the ability of H1 receptors from being activated by released histamine on endothelial cells and afferent nerve fibers. By preempting the histamine signal, Cetirizine influences subsequent capillary permeability changes and the transmission of sensory nerve signals.


Limited Central Nervous System (CNS) Activity

A crucial mechanistic feature of Cetirizine is its low capacity to cross the blood-brain barrier due to its physiochemical properties and active P-glycoprotein efflux. This restricts the drug’s binding predominantly to peripheral H1 receptors, ensuring that it minimally affects the H1 pathways in the brain. This peripheral selectivity results in a mechanism that primarily modulates peripheral H1 receptor activity, with minimal central H1 receptor engagement.


Secondary Anti-Inflammatory Modulation

Beyond the direct receptor blockade, the mechanism also involves a secondary influence on immune cells. Cetirizine has been shown to inhibit the chemotaxis (movement) and activation of specific inflammatory cells, such as eosinophils. This cellular effect influences the dynamics of the later phases of the inflammatory cascade by modulating cell accumulation, which alters the overall physiological response profile.

Dosage and Administration Information

How to Use Cetirizine (Cetrizet): Administration Guidelines

This section outlines the administration instructions for cetirizine. These directions define the standardized protocol for the medicine's proper usage.

Dosing and Administration

Population Group Recommended Daily Dose Administration Notes
Adults and Children 12 Years and Older 10 mg once daily Do not take more than 10 mg in 24 hours.
Children 6 to 11 Years 5 mg (half a tablet) twice daily, or 10 mg once daily Should not exceed 10 mg in a 24-hour period.
Adults 65 Years and Older Consult a healthcare professional. A lower dose (e.g., 5 mg once daily) may be recommended. Dosage may need adjustment due to age-related decline in kidney function.
Patients with Kidney or Liver Impairment Consult a healthcare professional for specific dose adjustment. Reduced dose (e.g., 5 mg once daily) is often necessary.

Procedural Instructions

Cetirizine is administered orally and may be taken with or without food. Oral tablets should be swallowed whole with a liquid.

If a dose is missed, take the dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take a double dose to compensate for a missed one. Following these instructions ensures the correct dosage and frequency are maintained, preventing administration errors and adhering to the use protocol.

Recent Clinical Evidence

Research evidence / Overview of Studies for Cetrizet

The research for Cetrizet, whose active ingredient is Cetirizine, has been studied for its use in two primary research contexts: allergic rhinitis (seasonal and perennial conditions) and chronic urticaria (conditions involving hives). The evidence landscape is largely defined by controlled clinical trials, which are the standard for regulatory assessment. The findings describe patterns observed in the studies and reflect the specific conditions under which they were conducted.


Evidence for Use in Allergic Rhinitis (Seasonal and Perennial)

The research conducted for this medication has resulted in a large body of evidence from clinical trials. Research has primarily involved Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These trials examined conditions characterized by fluctuating or unstable symptoms that occur both seasonally and year-round.

Researchers was studied for conditions where symptoms may vary in intensity by measuring changes in the Total Symptom Score (TSS), which is a composite score combining the intensity of nasal symptoms and ocular (eye) symptoms. Studies reported how symptoms evolved in the observed populations, with findings describing measured changes in the outcomes related to physical discomfort during the study period. For the primary research indication of allergic rhinitis, the evidence has been reviewed by authoritative bodies.


Evidence for Use in Chronic Hives (Urticaria)

Research examining the use of Cetrizet for chronic hives, or urticaria, has centered on double-blind, placebo-controlled trials and systematic reviews. This research was studied for conditions characterized by fluctuating or episodic manifestations of hives and itching.

The primary outcomes capturing phases of heightened symptom activity were monitored using the Urticaria Activity Score (UAS). This score is used to monitor the daily severity of both the physical weals and the intensity of the associated pruritus (itching). Research also examined the proportion of participants who reached the outcome of the maximum measured reduction in symptoms during the study period. Research provides insight into short-term changes associated with this chronic condition.


Research on Long-Term Outcomes and Durability

However, the long-term effects are not fully established beyond the one-year follow-up periods in the main randomized trial literature. There is limited information for long-term outcomes regarding the durability of the observed effect for individuals who rely on the medication continuously over many years. Research contributes to the broader evidence landscape but does not fully characterize multi-year maintenance patterns.

Key Studies & References

  1. Cetirizine: MedlinePlus Drug Information
  2. NICE Clinical Guideline: Assessment and management of allergic rhinitis

Frequently Asked Questions (FAQ)

Common questions about Cetrizet (FAQ)


Q: How long does it typically take for Cetrizet to start working after taking it?

According to official product information, the medicine's effect usually becomes measurable shortly after administration. Regulatory pharmacokinetics data indicates that the drug’s effects are typically measurable within 20 to 60 minutes following oral administration.


Q: What is the duration of action for a single dose of Cetrizet?

Official pharmacological data indicates that a single dose of the active ingredient, cetirizine, provides relief for an extended period. The duration of action is typically reported as approximately 24 hours, which aligns with its once-daily dosing.


Q: Is it okay to take Cetrizet every day for long-term allergy symptom management?

Clinical trials and regulatory data have studied cetirizine use for extended periods. However, regulatory information indicates that the long-term effects are not fully established beyond the standard trial follow-up periods. Patients who use the medicine daily for long periods should be informed that severe pruritus (itching) has been reported in some cases upon discontinuation.


Q: What happens if I stop taking Cetrizet suddenly after using it daily for a long time?

Official safety communications note that patients who discontinue long-term daily use of cetirizine have reported a specific reaction. The most frequently reported effect upon cessation is severe itching (pruritus), which typically appears within a few days of stopping the medication.


Q: Can Cetrizet cause any gastrointestinal issues like nausea, diarrhea, or constipation?

Yes, official safety information lists several reported gastrointestinal adverse effects. Nausea and diarrhea are listed among the common adverse reactions. Constipation has also been reported in post-marketing surveillance, though less frequently.


Q: Is there a risk of developing a fast or uneven heartbeat while taking Cetrizet?

Regulatory safety documents list both tachycardia (a rapid heart rate) and palpitations (an uneven heartbeat) as rare adverse reactions or post-marketing reports associated with the use of cetirizine.


Q: Can taking Cetrizet with other medications that cause sleepiness, like anxiety or sleep aids, increase the risk of drowsiness?

Yes. Official warnings advise caution with the concomitant use of CNS depressants, a category that includes many anxiety medications and sleep aids. Combining them with Cetrizet may cause an additive reduction in alertness and impaired performance.


Q: Does Cetrizet interact with any commonly used herbal supplements?

Official regulatory documents have limited information regarding the safety of combining Cetrizet with most herbal remedies or supplements. Caution is generally advised, particularly with supplements known to cause effects such as sleepiness, dry mouth, or difficulty urinating.


Q: Does Cetrizet affect liver function, or is a dose adjustment necessary for people with liver problems?

Official reports state that abnormal hepatic function (liver issues) has been reported rarely. Caution should be exercised in patients with impaired liver function, though isolated liver impairment may not always necessitate a formal dose adjustment according to all guidelines.


Q: Is there a special dose or concern for children under 6 years old taking Cetrizet?

Official product information specifies that Cetrizet tablets are not approved or recommended for use in children under 6 years old. Specific liquid formulations, however, may be approved for younger children, sometimes as young as 6 months for certain indications, with appropriate clinical guidance.


Q: Can Cetrizet cause restlessness or hyperactivity, especially in children?

Regulatory reports indicate that symptoms like restlessness and irritability may occur in cases of accidental overdose. In addition, clinical trial data in children has reported insomnia and general irritability/fussiness more frequently than with placebo.


Q: Is Cetrizet helpful for coughs or congestion not directly caused by an allergy?

The therapeutic indications for cetirizine are primarily restricted to the relief of symptoms associated with allergic conditions, such as allergic rhinitis and chronic hives. The drug’s use is primarily based on clinical evidence for allergic rhinitis and chronic hives.


Q: Can Cetrizet affect the central nervous system beyond causing drowsiness?

While Cetrizet is known for low sedation, regulatory documents list rare or very rare CNS effects. These include convulsions, involuntary movements like dyskinesia, vertigo, confusion, and anxiety.


Q: Does Cetrizet have any effect on blood pressure?

Regulatory adverse event reports list both hypertension (increased blood pressure) and hypotension (decreased blood pressure) as rare side effects that have been reported in association with the drug.


Q: Does Cetrizet contain any ingredients that could affect people with specific allergies or sensitivities, like to dyes?

The official product information specifies that the drug is contraindicated in patients with a known hypersensitivity to the active substance or to any of the excipients (inactive ingredients). Specific formulations may contain excipients that carry associated warnings, such as sorbitol or parahydroxybenzoates.


Q: Is there any research on Cetrizet's effectiveness for allergic asthma symptoms?

Studies have examined cetirizine in patients who have allergic rhinitis along with mild to moderate asthma. These studies showed that it improved the rhinitis symptoms and did not alter pulmonary function. It is important to note the drug is not officially indicated for the treatment of asthma itself.


Q: How does Cetrizet affect the immune system's response during an allergy?

Cetirizine's main role is blocking the Histamine H1-receptor. Its mechanism also includes a secondary effect on immune cells by inhibiting the chemotaxis (movement) and activation of inflammatory cells like eosinophils.


Q: Does Cetrizet need to be taken at a specific time of day (morning or evening)?

The recommended dosage is typically taken once daily. Regulatory information suggests that if an individual experiences drowsiness (somnolence), they may find it helpful to administer the dose in the evening.


Q: Can Cetirizine be used alongside steroid nasal sprays or medicated eye drops for allergies?

Official interaction studies have not identified clinically significant drug interactions with many other medications. It is generally understood that the drug may be used alongside local treatments like steroid nasal sprays or medicated eye drops.


Q: What is the half-life of Cetrizet's active component in the body?

Official pharmacokinetic data indicates how long the active component remains in the body. The mean elimination half-life of cetirizine in adults is approximately 8.3 hours.


Q: Can I take two different types of antihistamines, including Cetrizet, on the same day?

Regulatory guidance and general patient information recommend against the concurrent use of two different antihistamines. Combining them should only be done if specifically advised by a healthcare professional.


Q: Can Cetrizet cause a sore throat as a side effect?

Yes, regulatory safety documents list pharyngitis (sore throat) as a common adverse reaction. This means it has been reported in up to 1 in 10 patients.


Q: Will taking Cetrizet prevent future allergy attacks, or does it only treat the current symptoms?

The primary therapeutic purpose of Cetrizet is the symptomatic relief of allergic manifestations. It works to manage current symptoms but does not eliminate the underlying immunological cause of the allergy itself.


Q: Are people with epilepsy or seizure disorders advised against using Cetrizet?

Official safety information notes that caution is recommended for use in patients with epilepsy or those who have predisposing factors for convulsions. This is because occasional reports of convulsions have been associated with antihistamine use.


Q: Is there a risk of confusion as a side effect, particularly in older adults using Cetrizet?

Yes, confusion is listed in regulatory documents as a rare or very rare psychiatric adverse effect. As with many medications, increased caution should be exercised when the drug is used by older adults.


Q: Does Cetrizet work by constricting blood vessels, like decongestants do?

No. The drug’s main action is blocking the histamine H1 receptor. While it influences capillary permeability (how fluid passes through blood vessel walls), it is not a decongestant and does not have the vasoconstrictive (blood vessel constricting) action characteristic of those medicines.

How should Cetrizet be stored and disposed of?

Official Storage and Disposal Profile for Cetirizine

Storage and disposal requirements are based strictly on authoritative government regulatory documents.

Storage Requirements

Condition Requirement
Temperature Store at room temperature. Avoid excess heat and freezing (for specific formulations).
Container Keep medication in its original container, tightly closed.
Environment Protect from excess moisture and avoid storage in the bathroom. Protect specific forms (e.g., extended-release) from light.
Child Safety Must be stored out of sight and reach of children; always lock safety caps.

Disposal and Handling

Single-use ophthalmic containers must be used immediately after opening, and any remaining solution must be discarded along with the container. Orally disintegrating tablets must be handled with dry hands to prevent breakage. For outdated or unused oral medication, consult a pharmacist or doctor for the proper disposal protocol.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetrizet found in:

A-Z Index: